SNU-601Homo sapiens (Human)Cancer cell line

Also known as: NCI-SNU-601, SNU601

🤖 AI SummaryBased on 10 publications

Quick Overview

Human gastric cancer cell line with known ZAK isoform expression and genetic alterations.

Detailed Summary

SNU-601 is a human gastric cancer cell line derived from ascitic fluid. It exhibits specific genetic alterations, including the preferential upregulation of the ZAK kinase isoform TV1, which has been implicated in cancer progression. This cell line is valuable for studying the role of ZAK isoforms in gastric cancer and their potential as therapeutic targets. Additionally, SNU-601 has been used in studies involving drug sensitivity and resistance, particularly in the context of targeted therapies and chemotherapy. The cell line's genetic profile, including copy number variations and mutations, provides insights into the molecular mechanisms underlying gastric cancer development and progression.

Research Applications

Analysis of ZAK isoform expression and functionDrug sensitivity and resistance studiesGenomic and transcriptomic profilingTargeted therapy development

Key Characteristics

Preferential upregulation of ZAK TV1 isoformGenetic alterations including copy number variationsUse in studying gastric cancer molecular mechanisms
Generated on 6/14/2025

Basic Information

Database IDCVCL_0101
SpeciesHomo sapiens (Human)
Tissue SourceAscites[UBERON:UBERON_0007795]

Donor Information

Age34
Age CategoryAdult
SexMale
Raceasian

Disease Information

DiseaseGastric signet ring cell adenocarcinoma
LineageEsophagus/Stomach
SubtypeSignet Ring Cell Carcinoma of the Stomach
OncoTree CodeSSRCC

DepMap Information

Source TypeKCLB
Source IDACH-000736_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg273His (c.818G>A)Homozygous-Unknown, PubMed=16264262
MutationSimplePIK3CAp.Glu542Lys (c.1624G>A)Unspecified-PubMed=31541927
MutationSimpleKRASp.Gly12Asp (c.35G>A)Unspecified-PubMed=29786757

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10,11
D13S317
9,12
D16S539
12
D18S51
14
D21S11
29,30
D3S1358
16
D5S818
10
D7S820
9,11
D8S1179
13,14
FGA
23
Penta D
8,15
Penta E
11,18
TH01
7,9
TPOX
8,11
vWA
16,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

TDP1 and TOP1 modulation in olaparib-resistant cancer determines the efficacy of subsequent chemotherapy.

Kim T.-Y., Lee K.W., Oh D.-Y., Kim J.-H., Bang Y.-J.

Cancers (Basel) 12:334.1-334.17(2020).

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

van 't Veer L.J., Butte A.J., Goldstein T., Sirota M.

Nat. Commun. 10:3574.1-3574.11(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.

Kragh M., Horak I.D., Chung H.C., Rha S.Y.

Int. J. Cancer 143:151-159(2018).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.

OncoImmunology 3:e954893.1-e954893.12(2014).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.

Firestein R., Zhang Z.-M.

Nat. Commun. 5:3830.1-3830.8(2014).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Biology of SNU cell lines.";

Ku J.-L., Park J.-G.

Cancer Res. Treat. 37:1-19(2005).

Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization.

Okanoue T., Inazawa J.

Cancer Sci. 96:100-110(2005).

Characterization of chromosomal aberrations in human gastric carcinoma cell lines using chromosome painting.

Chun Y.-H., Kil J.-I., Suh Y.-S., Kim S.-H., Kim H., Park S.-H.

Cancer Genet. Cytogenet. 119:18-25(2000).

Establishment and characterization of human gastric carcinoma cell lines.

Bang Y.-J., Kim Y.I., Kim J.-P.

Int. J. Cancer 70:443-449(1997).